Capital Fund Management (CFM)’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.75M Buy
2025
Q1
Sell
2024
Q4
$1.08M Buy
2023
Q4
Sell
2023
Q3
$211K Sell
2023
Q2
$735K Buy
2022
Q3
Sell
2022
Q2
$924K Buy